Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
MannKind Corporation acquires scPharmaceuticals, significantly expanding its presence in cardiometabolic medicine with FUROSCIX, an FDA-approved treatment for heart and kidney disease. This strategic move aims to diversify revenue and accelerate growth.
Trump launched a "major" furniture tariff probe to boost U.S. manufacturing. Shares of import-heavy retailers (Wayfair, RH, Williams-Sonoma) fell, while U.S. makers (Ethan Allen, La-Z-Boy) rose. Industry opposes, citing no national security link and harm to U.S. jobs. Consumer prices are already up.
The Trump administration is seeking equity in semiconductor companies receiving CHIPS Act funds, signaling a major shift from traditional subsidies. Still, the Commerce Department is "not looking to take equity from TSMC and Micron."
Cenovus acquires MEG Energy for C$7.9B (cash/stock), forming an oil sands giant. Combined 720K+ bbls/d production, C$400M+ annual synergies by 2028. Reinforces Cenovus as a pre-eminent SAGD producer.
Walmart's second-quarter results exceeded revenue expectations due to e-commerce growth, but shares fell as profits missed forecasts for the first time in three years.
Amazon targets grocery dominance using Prime and same-day delivery, but Instacart, DoorDash, and Walmart have competitive strengths of their own. Can it overcome vast infrastructure and selection gaps?
